Your browser doesn't support javascript.
loading
One-step reverse transcriptase-free miRNA detection system and its application for detection of gastrointestinal cancers.
Zhao, Guodong; Xue, Ying; Dai, Yanmiao; Zhou, Xiaojin; Li, Hui; Sheng, Guangsen; Xu, Hongwei; Chen, Ying.
Afiliação
  • Zhao G; Zhejiang University of Technology, Zhejiang, Hangzhou 310014, China; ZJUT Yinhu Research Institute of Innovation and Entrepreneurship, Zhejiang, Hangzhou 311400, China; Department of Spleen and Stomach Diseases, Kunshan Hospital of Traditional Chinese Medicine, Kunshan Jiangsu 215300, China; State K
  • Xue Y; The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou Jiangsu 215000, China. Electronic address: xueying0304@126.com.
  • Dai Y; Department of Spleen and Stomach Diseases, Kunshan Hospital of Traditional Chinese Medicine, Kunshan Jiangsu 215300, China.
  • Zhou X; State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing 211189, China.
  • Li H; Department of Gastroenterology, The First People's Hospital of Xuzhou, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou Jiangsu 221002, China.
  • Sheng G; Clinical Laboratory, Xuzhou New Health Hospital, Xuzhou 221005, China.
  • Xu H; Department of Spleen and Stomach Diseases, Kunshan Hospital of Traditional Chinese Medicine, Kunshan Jiangsu 215300, China. Electronic address: niannian5727@126.com.
  • Chen Y; School of Medical Technology, Xuzhou Medical University, Xuzhou 221004, China. Electronic address: chenying@xzhmu.edu.cn.
Talanta ; 278: 126457, 2024 Oct 01.
Article em En | MEDLINE | ID: mdl-38917550
ABSTRACT
MicroRNAs (miRNAs) play pivotal roles in gene regulation and their dysregulation is implicated in various diseases, including cancer. Current methods for miRNA analysis often involve complex procedures and high costs, limiting their clinical utility. Therefore, there is a critical need for the development of simpler and more cost-effective miRNA detection techniques to enable early disease diagnosis. In this study, we introduce a novel one-enzyme for miRNA one-step detection method using Taq DNA polymerase, termed OSMOS-qPCR. We optimized the PCR buffer, PCR program, Taq DNA Polymerase concentrations and reverse PCR primer concentrations, resulted in a wide linear range from 100 fM to 0.001 fM (R2 > 0.98 for each miRNA), the detection limit for OSMOS-qPCR was 0.0025 fM. Furthermore, OSMOS-qPCR demonstrates excellent specificity to differentiation of less than 0.1 % nonspecific signal. Finally, we demonstrated the robust amplification efficiency, enabling the detection of trace amounts of cell-free miRNA in serum samples, and the excellent discrimination ability between gastrointestinal cancers and control subjects (AUC value = 1.0) if combined two miRNAs. The development of OSMOS-qPCR offering a simpler, cost-effective, and efficient detection method, has the potential to be non-invasive strategy for early detection of gastrointestinal cancers.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Gastrointestinais Limite: Humans Idioma: En Revista: Talanta Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: MicroRNAs / Neoplasias Gastrointestinais Limite: Humans Idioma: En Revista: Talanta Ano de publicação: 2024 Tipo de documento: Article